Lai Yichen, Chen Yaming, Watkins Simon C, Nathaniel Paula D, Guo Fengli, Kochanek Patrick M, Jenkins Larry W, Szabó Csaba, Clark Robert S B
Department of Critical Care Medicine, the Safar Center for Resuscitation Research and the Brain Trauma Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
J Neurochem. 2008 Mar;104(6):1700-11. doi: 10.1111/j.1471-4159.2007.05114.x. Epub 2007 Nov 6.
Poly-ADP-ribosylation is a post-translational modification performed by poly(ADP-ribose) polymerases (PARP), involved in many diverse cellular functions including DNA repair, transcription, and long-term potentiation. Paradoxically, PARP over-activation under pathologic conditions including traumatic brain injury (TBI) results in cell death. We previously demonstrated that intra-mitochondrial poly-ADP-ribosylation occurs following excitotoxic and oxidative injury in vitro. Here we sought to identify mitochondrial proteins modified by poly-ADP-ribosylation after TBI in vivo. Poly-ADP-ribosylation within mitochondria from injured brain after experimental TBI in rats was first verified using western blot and immuno-electron microscopy. Poly-ADP-ribosylated mitochondrial proteins identified using a targeted proteomic approach included voltage-dependent anion channel-1, mitofilin, mitochondrial stress proteins, and the electron transport chain components F1F0 ATPase, cytochrome c oxidase, and cytochrome c reductase. To examine the functional consequences of mitochondrial poly-ADP-ribosylation, isolated rat brain mitochondria were exposed to conditions of nitrosative stress known to activate PARP. PARP activation-induced reductions in State 3 respiration were prevented by the PARP-1 inhibitor 5-iodo-6-amino-1,2-benzopyrone or exogenous poly(ADP-ribose) glycohydrolase. As the effects of PARP activation on mitochondrial respiration appear regulated by poly(ADP-ribose) glycohydrolase, a direct effect of poly-ADP-ribosylation on electron transport chain function is suggested. These findings may be of relevance to TBI and other diseases where mitochondrial dysfunction occurs.
多聚 ADP 核糖基化是由多聚(ADP - 核糖)聚合酶(PARP)进行的一种翻译后修饰,参与包括 DNA 修复、转录和长时程增强等多种细胞功能。矛盾的是,在包括创伤性脑损伤(TBI)在内的病理条件下,PARP 的过度激活会导致细胞死亡。我们之前证明,在体外兴奋性毒性和氧化损伤后会发生线粒体内多聚 ADP 核糖基化。在此,我们试图确定在体内 TBI 后被多聚 ADP 核糖基化修饰的线粒体蛋白。首先使用蛋白质印迹法和免疫电子显微镜验证了实验性 TBI 后大鼠受伤脑线粒体中的多聚 ADP 核糖基化。使用靶向蛋白质组学方法鉴定出的多聚 ADP 核糖基化线粒体蛋白包括电压依赖性阴离子通道 1、线粒体融合蛋白、线粒体应激蛋白以及电子传递链成分 F1F0 ATP 合酶、细胞色素 c 氧化酶和细胞色素 c 还原酶。为了研究线粒体多聚 ADP 核糖基化的功能后果,将分离的大鼠脑线粒体暴露于已知可激活 PARP 的亚硝化应激条件下。PARP - 1 抑制剂 5 - 碘 - 6 - 氨基 - 1,2 - 苯并吡喃或外源性多聚(ADP - 核糖)糖苷水解酶可防止 PARP 激活诱导的状态 3 呼吸作用降低。由于 PARP 激活对线粒体呼吸的影响似乎受多聚(ADP - 核糖)糖苷水解酶调节,提示多聚 ADP 核糖基化对电子传递链功能有直接影响。这些发现可能与 TBI 和其他发生线粒体功能障碍的疾病相关。